GlaxoSmithKline Pharmaceuticals Limited
GLAXO

GlaxoSmithKline Pharmaceuticals Limited

Healthcare
Share price
₹2,728
Market cap
₹46,290 Cr
1Y return
▲ 11%

A leading pharmaceutical company, GlaxoSmithKline Pharmaceuticals researches, manufactures, and distributes a broad range of medicines and vaccines across India and internationally. The company operates across multiple therapeutic areas including respiratory, oncology, dermatology, and vaccines, serving healthcare providers and patients. Its integrated operations span drug development, manufacturing, quality assurance, and distribution networks throughout the country and beyond.

Investors holding GlaxoSmithKline Pharmaceuticals Limited

1.05%
1.01%

Recent moves 3

LICExited
LIC's name is missing from the latest GlaxoSmithKline Pharmaceuticals Limited update, indicating the investor either fully exited or trimmed its previous 1.08 percent stake below the 1 percent reporting threshold.
12 Oct 2026
Read more
Nippon India Mutual FundNew position
Nippon India Mutual Fund's holding in GlaxoSmithKline Pharmaceuticals was newly disclosed at 1.05%, with the fund holding 17,76,623 shares.
12 Oct 2026
Read more
Quant Mutual FundNew position
Quant Mutual Fund disclosed a new 1.01% stake in GlaxoSmithKline Pharmaceuticals Limited. The mutual fund holds 17,11,332 shares, crossing the 1% public disclosure threshold.
12 Oct 2026
Read more

Track the whales in GlaxoSmithKline Pharmaceuticals Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1